Mean values (± standard deviation) of electrolyte concentrations before and after CWI. by Aneta Teległów (9570190)

Subjects:

Mean values (± standard deviation) of lipid profile parameters before and after CWI. by Aneta Teległów (9570190)

Subjects:

Correlation between relative amounts of lipid species and number of days since the onset of symptoms among COVID-19 cases. by Spela Kokelj (8356644)

Subjects:

Correlation between protein abundances and R_5-20 z-score among cases at baseline. Protein abundances, normalized to mean 0 and variance 1, are displayed on the y-axis. (... by Spela Kokelj (8356644)

Subjects:

General characteristics and clinical data of the subjects included in the study. by Spela Kokelj (8356644)

Subjects:

Distribution of average relative amounts of lipid classes. by Spela Kokelj (8356644)

Subjects:

Flow chart on the inclusion and drop out of patients. by Spela Kokelj (8356644)

Subjects:

Differentially abundant lipid species in COVID-19 cases at baseline and at follow-up as compared to healthy controls. by Spela Kokelj (8356644)

Subjects:

Symptoms reported by COVID-19 cases at baseline and at follow-up. by Spela Kokelj (8356644)

Subjects:

Raw data. by Changzhi Liu (518454)

“…The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). …”

Baseline characteristics of the subjects. by Changzhi Liu (518454)

“…The incidence of fractures was significantly greater among participants with low RC levels than among those with high RC levels (6.4% vs. 3.1%, P < 0.01). …”

Mean case duration before and after intervention (t-statistic = -3.35, p <i>< </i>0.001), indicating a statistically significant difference in means. by Mohammad Bakhtiari (11838264)

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Utilization of anticoagulants at eight hospitals from 2019 to 2023. by Wei Luo (80175)

Subjects:

The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects:

Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

Subjects:

Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

Subjects:

Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

Subjects: